For the long-term management of pernicious anemia after B12 replenishment, parenteral treatment with B12 every 13 months seems sufficient to prevent a relapse [13,14,15]
Who should avoid Epithalon Absolute contraindications: Pregnancy or breastfeeding (no safety data) Active cancer diagnosis (telomerase concerns) Children and adolescents (still developing) Severe kidney or liver disease (clearance issues) Relative contraindications (use caution): Autoimmune conditions (immune stimulation could worsen) History of cancer (even if in remission - discuss with oncologist) Severe sleep disorders (pineal effects unpredictable) Taking immunosuppressants (opposing effects) Severe mental health conditions (monitor carefully) When to consult physician: Any chronic medical conditions Taking prescription medications History of adverse peptide reactions Uncertain about appropriateness Want medical monitoring during treatment Age considerations: Under 30: Questionable benefit (telomeres still long, aging minimal ) 30-50: Preventive use reasonable, moderate benefits 50+: Best candidates, age-related decline more pronounced 70+: Still beneficial but more medical monitoring advised Find peptide therapy clinics for supervised treatment at SeekPeptides
BPC is short for body protection compound because its derived from a protein found in the stomach where its role is protecting and healing the horse's gut
Verificate che il GHK-Cu (spesso indicato con il nome INCI "Copper Tripeptide-1") compaia tra i primi ingredienti della lista INCI, indicando una concentrazione significativa
Different concentrations of the CuSO 4 solution were prepared by mixing 0, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.1, 1.2, and 1.3 equivalents of recombinant GHK peptides to a final volume of 1 mL
